Cargando…

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [(18)F]DiFA and comparison with [(18)F]FMISO

BACKGROUND: To facilitate hypoxia imaging in a clinical setting, we developed 1-(2,2-dihydroxymethyl-3-[(18)F]-fluoropropyl)-2-nitroimidazole ([(18)F]DiFA) as a new tracer that targets tumor hypoxia with its lower lipophilicity and efficient radiosynthesis. Here, we evaluated the radiation dosage, b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Shiro, Shiga, Tohru, Hirata, Kenji, Magota, Keiichi, Okamoto, Shozo, Toyonaga, Takuya, Higashikawa, Kei, Yasui, Hironobu, Kobayashi, Jun, Nishijima, Ken-ichi, Iseki, Ken, Matsumoto, Hiroki, Kuge, Yuji, Tamaki, Nagara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611855/ https://www.ncbi.nlm.nih.gov/pubmed/31278504 http://dx.doi.org/10.1186/s13550-019-0525-6

Ejemplares similares

Voxel based comparison and texture analysis of (18)F-FDG and (18)F-FMISO PET of patients with head-and-neck cancer
por: Kroenke, Markus, et al.
Publicado: (2019)

Elimination of tumor hypoxia by eribulin demonstrated by (18)F-FMISO hypoxia imaging in human tumor xenograft models
por: Zhao, Songji, et al.
Publicado: (2019)

Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
por: Watanabe, Shiro, et al.
Publicado: (2019)

Evaluation of the biodistribution and radiation dosimetry of the (18)F-labelled amyloid imaging probe [(18)F]FACT in humans
por: Shidahara, Miho, et al.
Publicado: (2013)

Increased [(18)F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors
por: Shimizu, Yoichi, et al.
Publicado: (2021)

FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state
por: Masaki, Yukiko, et al.
Publicado: (2017)

Preclinical biodistribution and dosimetry and human biodistribution comparing (18)F-rhPSMA-7 and single isomer (18)F-rhPSMA-7.3
por: Knorr, Karina, et al.
Publicado: (2022)

Anti PD-1 treatment increases [(18)F]FDG uptake by cancer cells in a mouse B16F10 melanoma model
por: Tomita, Mayu, et al.
Publicado: (2018)

Human biodistribution and radiation dosimetry of the demyelination tracer [(18)F]3F4AP
por: Brugarolas, Pedro, et al.
Publicado: (2022)

Biological characteristics of intratumoral [F-18]-fluoromisonidazole distribution in a rodent model of glioma
por: HATANO, TOSHIYUKI, et al.
Publicado: (2013)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
por: Thureau, Sébastien, et al.
Publicado: (2021)

Noninvasive evaluation of (18)F-FDG/(18)F-FMISO-based Micro PET in monitoring hepatic metastasis of colorectal cancer
por: Zhang, Mingyu, et al.
Publicado: (2018)

Automated radiosynthesis of two (18)F-labeled tracers containing 3-fluoro-2-hydroxypropyl moiety, [(18)F]FMISO and [(18)F]PM-PBB3, via [(18)F]epifluorohydrin
por: Ohkubo, Takayuki, et al.
Publicado: (2021)

[(18)F]DPA-714 PET imaging shows immunomodulatory effect of intravenous administration of bone marrow stromal cells after transient focal ischemia
por: Tan, Chengbo, et al.
Publicado: (2018)

Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and (18)F-fluoromisonidazole hypoxia imaging in renal cell carcinoma
por: MURAKAMI, MASAHIRO, et al.
Publicado: (2012)

Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [(18)F]-tetrafluoroborate
por: Marti-Climent, J. M., et al.
Publicado: (2015)

The clinical safety, biodistribution and internal radiation dosimetry of [(18)F]AH113804 in healthy adult volunteers
por: Somer, E. J., et al.
Publicado: (2016)

Safety, Biodistribution, and Radiation Dosimetry of (18)F-rhPSMA-7.3 in Healthy Adult Volunteers
por: Tolvanen, Tuula, et al.
Publicado: (2021)

Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors
por: Nishikawa, Yukiko, et al.
Publicado: (2017)

Kinetic Evaluation of the Hypoxia Radiotracers [(18)F]FMISO and [(18)F]FAZA in Dogs with Spontaneous Tumors Using Dynamic PET/CT Imaging
por: Choen, Sangkyung, et al.
Publicado: (2022)

The accumulation mechanism of the hypoxia imaging probe “FMISO” by imaging mass spectrometry: possible involvement of low-molecular metabolites
por: Masaki, Yukiko, et al.
Publicado: (2015)

Radiation dosimetry of florbetapir F 18
por: Joshi, Abhinay D, et al.
Publicado: (2014)

[(18)F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer
por: Yamane, Tomohiko, et al.
Publicado: (2019)

Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT
por: Fatema, Chowdhury Nusrat, et al.
Publicado: (2014)

The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol ((18)F) injection in healthy Japanese adult volunteers
por: Senda, Michio, et al.
Publicado: (2015)

Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy
por: Tong, Xiao, et al.
Publicado: (2016)

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
por: Giesel, Frederik L., et al.
Publicado: (2016)

Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: (18)F-AZD9272
por: Nag, Sangram, et al.
Publicado: (2020)

Comparison of (18)F-FES, (18)F-FDG, and (18)F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer
por: He, SiMin, et al.
Publicado: (2016)

Sequential [(18)F]FDG-[(18)F]FMISO PET and Multiparametric MRI at 3T for Insights into Breast Cancer Heterogeneity and Correlation with Patient Outcomes: First Clinical Experience
por: Andrzejewski, Piotr, et al.
Publicado: (2019)

Evaluation of (18)F-FMISO PET and (18)F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy
por: Lee, Sze Ting, et al.
Publicado: (2021)

Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma
por: Thézé, Benoît, et al.
Publicado: (2015)

Radiation dosimetry of [(18)F]VAT in nonhuman primates
por: Karimi, Morvarid, et al.
Publicado: (2015)

Good practices for the automated production of (18)F-SiFA radiopharmaceuticals
por: Blok, Simon, et al.
Publicado: (2023)

A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using (18)F-FMISO-PET
por: Rockne, Russell C., et al.
Publicado: (2015)

Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and (18)F-FMISO PET
por: Huang, Shiliang, et al.
Publicado: (2021)

Synthesis of [(18)F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist’s perspective
por: Kniess, Torsten, et al.
Publicado: (2023)

Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
por: Yamaguchi, Shigeru, et al.
Publicado: (2016)

Safety, pharmacokinetics, metabolism and radiation dosimetry of (18)F-tetrafluoroborate ((18)F-TFB) in healthy human subjects
por: Jiang, Huailei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ch12742ijv81mllnr3pv8vs59v